{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T21:47:31Z","timestamp":1776116851463,"version":"3.50.1"},"reference-count":27,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.3892\/ijo.2013.2144","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T06:39:15Z","timestamp":1382078355000},"page":"2073-2081","source":"Crossref","is-referenced-by-count":7,"title":["Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines"],"prefix":"10.3892","volume":"43","author":[{"given":"JA-LOK","family":"KU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SUNG-CHAN","family":"PARK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KYUNG-HEE","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOU-KYUNG","family":"JEON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SUNG-HEE","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOUNG-KYOUNG","family":"SHIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DONG-YOUNG","family":"NOH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SEOCK-AH","family":"IM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUNG-JUE","family":"BANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WONSHIK","family":"HAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WOO HO","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JAE-GAHB","family":"PARK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,10,18]]},"reference":[{"key":"key20180107183436_b1-ijo-43-06-2073","volume-title":"DeVita, Hellman, and Rosenberg\u2019s Cancer: Principles & Practice of Oncology","author":"DeVita","year":"2008"},{"key":"key20180107183436_b2-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccr.2006.10.008","article-title":"A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes","volume":"10","author":"Neve","year":"2006","journal-title":"Cancer Cell"},{"key":"key20180107183436_b3-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L","article-title":"Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer","volume":"78","author":"Gazdar","year":"1998","journal-title":"Int J Cancer"},{"key":"key20180107183436_b4-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/B:BREA.0000014042.54925.cc","article-title":"Relevance of breast cancer cell lines as models for breast tumours: an update","volume":"83","author":"Lacroix","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107183436_b5-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/bcr577","article-title":"Breast cancer cell lines: friend or foe?","volume":"5","author":"Burdall","year":"2003","journal-title":"Breast Cancer Res"},{"key":"key20180107183436_b6-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.2910620308","article-title":"Characterization of cell lines established from human hepatocellular carcinoma","volume":"62","author":"Park","year":"1995","journal-title":"Int J Cancer"},{"key":"key20180107183436_b7-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.bjc.6600440","article-title":"Establishment and characterisation of six human biliary tract cancer cell lines","volume":"87","author":"Ku","year":"2002","journal-title":"Br J Cancer"},{"key":"key20180107183436_b8-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mce.2006.10.017","article-title":"Establishment and characterization of cell lines from three human thyroid carcinomas: responses to all-trans-retinoic acid and mutations in the BRAF gene","volume":"264","author":"Koh","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"key20180107183436_b9-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3835(01)00739-X","article-title":"Expression of estrogen receptor-alpha and -beta mRNAs in human gastric cancer","volume":"176","author":"Takano","year":"2002","journal-title":"Cancer Lett"},{"key":"key20180107183436_b10-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s004320100294","article-title":"Androgen receptor status in female breast cancer: RT-PCR and Western blot studies","volume":"128","author":"Brys","year":"2002","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107183436_b11-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1368-8375(01)00029-X","article-title":"C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors","volume":"38","author":"O-charoenrat","year":"2002","journal-title":"Oral Oncol"},{"key":"key20180107183436_b12-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1182\/blood.V95.10.3208","article-title":"Hypermethylation of E-cadherin in leukemia","volume":"95","author":"Melki","year":"2000","journal-title":"Blood"},{"key":"key20180107183436_b13-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/S0959-8049(03)00485-4","article-title":"Cyclooxygenase-1 and -2 in human testicular tumours","volume":"39","author":"Hase","year":"2003","journal-title":"Eur J Cancer"},{"key":"key20180107183436_b14-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0006-2952(00)00396-8","article-title":"BCRP\/MXR\/ABCP expression in topotecan-resistant human breast carcinoma cells","volume":"60","author":"Yang","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"key20180107183436_b15-ijo-43-06-2073","first-page":"3228","article-title":"Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin","volume":"63","author":"Rajendra","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107183436_b16-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00018-009-8562-3","article-title":"Galectin-3 stabilizes heterogeneous nuclear ribonucleoprotein Q to maintain proliferation of human colon cancer cells","volume":"66","author":"Yoo","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"key20180107183436_b17-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/(SICI)1097-0215(19960917)67:6<898::AID-IJC22>3.0.CO;2-X","article-title":"Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA","volume":"67","author":"Kang","year":"1996","journal-title":"Int J Cancer"},{"key":"key20180107183436_b18-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1078-0432.1167.11.3","article-title":"The relationship between epidermal growth factor receptor mutations and clinicopatho-logic features in non-small cell lung cancers","volume":"11","author":"Tokumo","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20180107183436_b19-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1074\/mcp.M200008-MCP200","article-title":"Discordant protein and mRNA expression in lung adenocarcinomas","volume":"1","author":"Chen","year":"2002","journal-title":"Mol Cell Proteomics"},{"key":"key20180107183436_b20-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1159\/000185629","article-title":"Discrepancy between intra-renal messenger RNA and protein expression of ACE and ACE2 in human diabetic nephropathy","volume":"29","author":"Wang","year":"2008","journal-title":"Am J Nephrol"},{"key":"key20180107183436_b21-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"R374","DOI":"10.1186\/bcr1012","article-title":"c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study","volume":"7","author":"Fritz","year":"2005","journal-title":"Breast Cancer Res"},{"key":"key20180107183436_b22-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1158\/0008-5472.CAN-06-0321","article-title":"Effect of c-neu\/ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology","volume":"66","author":"Shyamala","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107183436_b23-ijo-43-06-2073","first-page":"5239","article-title":"Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53","volume":"63","author":"Swamy","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107183436_b24-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.pai.0000213130.63417.b3","article-title":"COX-2 expression in invasive breast cancer: correlation with prognostic parameters and outcome","volume":"15","author":"Nassar","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"key20180107183436_b25-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"p53 mutations in human cancers","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science"},{"key":"key20180107183436_b26-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/mcbr.2000.0241","article-title":"p53 codon 72 polymorphism as a risk factor in the development of breast cancer","volume":"3","author":"Papadakis","year":"2000","journal-title":"Mol Cell Biol Res Commun"},{"key":"key20180107183436_b27-ijo-43-06-2073","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1093","article-title":"The codon 72 polymorphic variants of p53 have markedly different apoptotic potential","volume":"33","author":"Dumont","year":"2003","journal-title":"Nat Genet"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2013.2144\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T11:39:52Z","timestamp":1688557192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2013.2144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,18]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,10,18]]},"published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.3892\/ijo.2013.2144"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2013.2144","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,18]]}}}